Richard T Kenney insider trades
Open-market stock purchases and sales by Richard T Kenney, Chief Medical Officer at Sonnet BioTherapeutics Holdings, Inc, from SEC Form 4 filings since Jan 7, 2015.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Dec 2, 2025 | SONN Sonnet BioTherapeutics Holdings, Inc | Sold (not open market) | — |
| Dec 2, 2025 | SONN Sonnet BioTherapeutics Holdings, Inc | Sold (not open market) | — |
| Dec 2, 2025 | SONN Sonnet BioTherapeutics Holdings, Inc | Sold (not open market) | — |
| Dec 2, 2025 | SONN Sonnet BioTherapeutics Holdings, Inc | Bought (not open market) | — |
| Dec 2, 2025 | SONN Sonnet BioTherapeutics Holdings, Inc | Sold (not open market) | — |
| Dec 2, 2025 | SONN Sonnet BioTherapeutics Holdings, Inc | Bought (not open market) | $100K |
| Dec 2, 2025 | SONN Sonnet BioTherapeutics Holdings, Inc | Sold (not open market) | $400K |
| Dec 2, 2025 | SONN Sonnet BioTherapeutics Holdings, Inc | Bought (not open market) | $250 |